Tag Archives: Sixth trial of Chinese COVID-19 vaccine begins

A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters from UK’s GSK and US based Dynavax. The trial, which is enrolling about 150 adult and elderly patients, will evaluate the two different boosters, or adjuvants, in combination with Clover’s …

Read More »